Kevin Pegels - Illumina Chief Operations

ILU Stock  EUR 136.18  0.26  0.19%   

Insider

Kevin Pegels is Chief Operations of Illumina
Phone858 202 4500
Webhttps://www.illumina.com

Illumina Management Efficiency

Illumina's management efficiency ratios could be used to measure how well Illumina manages its routine affairs as well as how well it operates its assets and liabilities.
Illumina has accumulated 1.49 B in total debt with debt to equity ratio (D/E) of 0.58, which is about average as compared to similar companies. Illumina has a current ratio of 4.36, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Illumina until it has trouble settling it off, either with new capital or with free cash flow. So, Illumina's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Illumina sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Illumina to invest in growth at high rates of return. When we think about Illumina's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Joakim WeidemanisDanaher
54
MBA MBASuperior Plus Corp
70
Ingrid EngstromSIVERS SEMICONDUCTORS AB
59
Steven HumphreysIdentiv
62
Erik WiklundSIVERS SEMICONDUCTORS AB
49
CCLP CMASuperior Plus Corp
62
Patric ErlandssonSIVERS SEMICONDUCTORS AB
51
Amir KhoshniyatiIdentiv
N/A
Justin ScarpullaIdentiv
50
FCA FCASuperior Plus Corp
68
Pal KildemoNorsk Hydro ASA
39
Sven PetterssonSIVERS SEMICONDUCTORS AB
60
Caroline SchlienkampTalanx AG
49
Edward KirnbauerIdentiv
58
Harry KanwarSuperior Plus Corp
N/A
Angela LalorDanaher
58
Ash RajendraSuperior Plus Corp
N/A
Hilde NordhNorsk Hydro ASA
54
Bernd SablowskyTalanx AG
53
Christopher LohmannTalanx AG
55
Steve DunlapIdentiv
N/A
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. The company was incorporated in 1998 and is headquartered in San Diego, California. ILLUMINA INC operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 7800 people. Illumina (ILU) is traded on Frankfurt Exchange in Germany and employs 11,500 people.

Management Performance

Illumina Leadership Team

Elected by the shareholders, the Illumina's board of directors comprises two types of representatives: Illumina inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Illumina. The board's role is to monitor Illumina's management team and ensure that shareholders' interests are well served. Illumina's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Illumina's outside directors are responsible for providing unbiased perspectives on the board's policies.
Julian Andrews, Head of Strategy and Planning and Head of Business Development and Group Rehabilitation
James Ranck, Non-Executive Independent Director
Francis deSouza, CEO Director
Lynne Saint, Non-Executive Independent Director
Charles Dadswell, Gen VP
Adele Stratton, General Manager - Finance, Investor Relations and Corporate Affairs
Marcelo Bastos, Independent Non-Executive Director
Susan Wilson, General Counsel, Company Secretary
Gregory Martin, Non-Executive Independent Chairman of the Board
Shane Tilka, General Manager - Jacinth-Ambrosia & Midwest
Thomas OLeary, Chief Executive Officer, Managing Director, Executive Director
Susie Corlett, Non-Executive Independent Director
Christian Barbier, Head of Marketing
Scott Ericksen, VP Officer
Kevin Pegels, Chief Operations
Nigel Tinley, Joint Company Secretary
Joydeep MBA, Chief CFO
Rob Hattingh, Chief Executive Officer - Sierra Rutile
Sallilyn Schwartz, VP Relations
Susan Tousi, Chief Officer
Daniel McGrath, General Manager - Cataby and Southwest
Matthew Blackwell, Head of Major Projects, Engineering & Innovation
Melissa Roberts, General Manager - Investor Relations and Commercial Mineral Sands Operations
Tim Bartholomew, General Manager - Strategic Development & Closure
Sarah Hodgson, General Manager - People and Sustainability
Alexander MD, CTO Devel
Stephanie Campos, President
Carissa Rollins, Chief Officer
Robert Cole, Non-Executive Independent Director

Illumina Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Illumina a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Illumina Stock

When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Illumina Stock please use our How to Invest in Illumina guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.